2023-05-23 10:48:45
Ildong Holdings and Ildong Pharmaceuticals will start a business renewal.
On the 23rd, Ildong Pharmaceutical Group announced to internal members a plan for reform, including efficiency in research costs, promotion of early license out (L/O) of pipelines, item restructuring, and employee ERP.
This renewal plan focused on preparing for the rapidly changing financial market environment, such as rising interest rates, and above all, realizing profits through business restructuring and generating early results in the R&D field.
First of all, in the field of R&D, it was decided to adjust the plan to increase efficiency and speed and speed up the license out.
In the field of sales and marketing, it was decided to boldly dispose of items with a weak profit structure and minimize the cost burden through rational safety stock management.
In addition, more than 20% of the executives of Ildong Holdings and Ildong Pharmaceutical were cut, and they agreed to return 20% of the salaries of the remaining executives, and decided to operate ERP for employees at the executive level of deputy manager or higher to receive applications for voluntary retirement.
Through this, it plans to reorganize into a rational organization such as organizational integration and redeployment to achieve efficient resource management and sales targets.
An official from Ildong Holdings emphasized, “This voluntary renewal is to minimize financial risks and accelerate the achievement of the vision.”
1684847321
#Ildong #Pharmaceutical #begins #restructuring.. #Executive #level #ERP #operation
